Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
Aim: To study the efficacy of autovaccine in the treatment of gastric cancer and significance of molecular factors having prognostic values for disease outcome to evaluate its efficacy in clinical setting. Patients and Methods: 150 patients with histologically proven adenocarcinoma of the stomach of...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2009 |
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2009
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/138135 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue / V.M. Bazas, N.Yu. Lukyanova, G.S. Lisovenko, D.O. Rozumiy, G.P. Potebnya // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 182-184. — Бібліогр.: 18 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of Ukraine| _version_ | 1862613485022609408 |
|---|---|
| author | Bazas, V.M. Lukyanova, N.Yu. Lisovenko, G.S. Rozumiy, D.O. Potebnya, G.P. |
| author_facet | Bazas, V.M. Lukyanova, N.Yu. Lisovenko, G.S. Rozumiy, D.O. Potebnya, G.P. |
| citation_txt | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue / V.M. Bazas, N.Yu. Lukyanova, G.S. Lisovenko, D.O. Rozumiy, G.P. Potebnya // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 182-184. — Бібліогр.: 18 назв. — англ. |
| collection | DSpace DC |
| container_title | Experimental Oncology |
| description | Aim: To study the efficacy of autovaccine in the treatment of gastric cancer and significance of molecular factors having prognostic values for disease outcome to evaluate its efficacy in clinical setting. Patients and Methods: 150 patients with histologically proven adenocarcinoma of the stomach of stages II, III or IV were enrolled into study. 86 patients have been treated with autovaccine (AV) after operation. Expression of p53, Bcl-2, receptors of tyrosine kinase, vascular endothelial growth factor (VEGF), Е-cadherin, α-catenin and β-catenin was determined in paraffin embedded tumor samples by means of immunohistochemical method with the use of respective monoclonal antibodies. Results: It was shown that application of AV has resulted in the increase of 3-year overall survival of patients having stage III of disease by more than 30%, but those having stage IV — only around 14%. The increase of 3-year overall survival of patients with metastases in lymph nodes (N1–2) was observed also in more than 30%. It has been suggested the optimal phenotype for vaccine application: р53(+), EGFR(+), HER-2 neu (+), β-catenin (+), VEGF(+) and Bcl-2(+) with no dependence on E-cadherin and α-catenin presence. Conclusion: It was determined that the best effect of AV application is observed in patients with category Т3–4, poorly-differentiated tumors, metastases in lymph nodes (N1–2), but without distant metastases (М0). Gastric cancer patients with p53, EGFR, HER-2/neu, β-catenin, VEGF and Bcl-2-positive tumors are the favorable group for the treatment with AV in the adjuvant regime.
|
| first_indexed | 2025-11-29T07:12:39Z |
| format | Article |
| fulltext | |
| id | nasplib_isofts_kiev_ua-123456789-138135 |
| institution | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| issn | 1812-9269 |
| language | English |
| last_indexed | 2025-11-29T07:12:39Z |
| publishDate | 2009 |
| publisher | Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| record_format | dspace |
| spelling | Bazas, V.M. Lukyanova, N.Yu. Lisovenko, G.S. Rozumiy, D.O. Potebnya, G.P. 2018-06-18T09:39:30Z 2018-06-18T09:39:30Z 2009 Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue / V.M. Bazas, N.Yu. Lukyanova, G.S. Lisovenko, D.O. Rozumiy, G.P. Potebnya // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 182-184. — Бібліогр.: 18 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/138135 Aim: To study the efficacy of autovaccine in the treatment of gastric cancer and significance of molecular factors having prognostic values for disease outcome to evaluate its efficacy in clinical setting. Patients and Methods: 150 patients with histologically proven adenocarcinoma of the stomach of stages II, III or IV were enrolled into study. 86 patients have been treated with autovaccine (AV) after operation. Expression of p53, Bcl-2, receptors of tyrosine kinase, vascular endothelial growth factor (VEGF), Е-cadherin, α-catenin and β-catenin was determined in paraffin embedded tumor samples by means of immunohistochemical method with the use of respective monoclonal antibodies. Results: It was shown that application of AV has resulted in the increase of 3-year overall survival of patients having stage III of disease by more than 30%, but those having stage IV — only around 14%. The increase of 3-year overall survival of patients with metastases in lymph nodes (N1–2) was observed also in more than 30%. It has been suggested the optimal phenotype for vaccine application: р53(+), EGFR(+), HER-2 neu (+), β-catenin (+), VEGF(+) and Bcl-2(+) with no dependence on E-cadherin and α-catenin presence. Conclusion: It was determined that the best effect of AV application is observed in patients with category Т3–4, poorly-differentiated tumors, metastases in lymph nodes (N1–2), but without distant metastases (М0). Gastric cancer patients with p53, EGFR, HER-2/neu, β-catenin, VEGF and Bcl-2-positive tumors are the favorable group for the treatment with AV in the adjuvant regime. Authors thank Dr. L.N. Bubnovskaya, Ph.D. for her helpful assistance. en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Short communications Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue Article published earlier |
| spellingShingle | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue Bazas, V.M. Lukyanova, N.Yu. Lisovenko, G.S. Rozumiy, D.O. Potebnya, G.P. Short communications |
| title | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue |
| title_full | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue |
| title_fullStr | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue |
| title_full_unstemmed | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue |
| title_short | Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue |
| title_sort | postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue |
| topic | Short communications |
| topic_facet | Short communications |
| url | https://nasplib.isofts.kiev.ua/handle/123456789/138135 |
| work_keys_str_mv | AT bazasvm postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue AT lukyanovanyu postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue AT lisovenkogs postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue AT rozumiydo postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue AT potebnyagp postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue |